Research articlePublished 2015
Successful Induction of Pluripotent Stem Cells From a Fabry Disease Mouse Model: Toward the Development of Safe Lentiviral Gene Therapy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Induced pluripotent stem (iPS) cells are now recognized as a valuable tool for cell repair through autologous transplantation. These cells are obtainable from somatic cells through the induction of the transcriptional factors Oct- 3/4, Klf4, and Sox2. In this study, we successfully established iPS cells from the tail-tip fibroblasts of a α-galactosidase A-knockout mouse, a well-known Fabry disease mouse model. These Fabry-iPS cells exhibited an embryonic stem (ES) cell phenotype, characterized by the expression of SSEA-1, increased alkaline phosphatase activity, silencing of the retroviral-transgene, and embryoid body (EB) formation. Subcutaneous inoculation of Fabry-iPS cells into nude mice resulted in teratoma formation. At day 6, EBs in differentiation media showed hematopoietic lineage-specific gene expression. In addition, we observed spontaneous contraction of EBs cultured on OP9 stroma cells for 5-7 days. RT-PCR demonstrated that various cardiac marker genes, such as Nkx2.5, Gata4, Tnnt2 (cardiac troponin T), and Mlc2a were more highly expressed in differentiation cultures of Fabry iPS cells than of control feeder cells. To assess their potential use for gene therapy, lentiviral transduction of Fabry-iPS cells with α-galactosidase-A cDNA, the therapeutic gene for Fabry disease, was performed. This transduction resulted in elevated intracellular and secreted α-galactosidase A activity. The ES cell-specific gene expression profile remained unaltered by lentiviral therapeutic gene transfer for more than 30 days post-transduction. These findings demonstrate that Fabry-iPS cells are readily obtainable and amenable for use in gene therapy.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Makoto Yoshimitsu”
- BylineArticles whose byline prints “Koji Higuchi”
- BylineArticles whose byline prints “Naomichi Arima”
- BylineArticles whose byline prints “Jeffrey A Medin”
- BylineArticles whose byline prints “Toshihiro Takenaka”
